AI assistant

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

HARVARD BIOSCIENCE INC Director's Dealing 2023

Jan 3, 2023

34975_dirs_2023-01-03_83ce4c2d-b9cb-4f7b-9cd2-bbedb79851df.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: HARVARD BIOSCIENCE INC (HBIO)
CIK: 0001123494
Period of Report: 2023-01-01

Reporting Person: Cote Jennifer (Interim CFO)

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	30334	Direct

Footnotes

F1: Represents (a) 22,342 restricted stock units that will vest in two equal installments on December 29, 2023 and 2024 and (b) 7,992 shares of common stock beneficially owned by the Reporting Person.